Piramal Pharma (NSE:PPLPHARMA) Receivables Turnover : 1.23 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Piramal Pharma's Revenue for the three months ended in Sep. 2024 was ₹22,418 Mil. Piramal Pharma's average Accounts Receivable for the three months ended in Sep. 2024 was ₹18,271 Mil. Hence, Piramal Pharma's Receivables Turnover for the three months ended in Sep. 2024 was 1.23.

Piramal Pharma Receivables Turnover Historical Data

The historical data trend for Piramal Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Receivables Turnover Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

3.45

4.93

3.92

4.12

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Receivables Turnover	Get a 7-Day Free Trial									1.10	1.12	1.17	0.91	1.23

Competitive Comparison of Piramal Pharma's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Receivables Turnover falls into.

Piramal Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Piramal Pharma's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	81064.1	/ (	(17993.4	+	21344.3)	/	2 )
=	81064.1	/	19668.85
=	4.12

Piramal Pharma's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	22417.5	/ (	(0	+	18271.4)	/	1 )
=	22417.5	/	18271.4
=	1.23

Piramal Pharma (NSE:PPLPHARMA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Piramal Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Receivables Turnover

Traded in Other Exchanges

543635:India

Address

Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines